EAACI Congress 2023
BackDrug allergy – time for a personalised approach
Friday 09 Jun, 13:15 PM -
14:45 PM CEST
Hall Y 05+06
ORAL Session
13:15
Comparison of the passive mast cell activation tests with basophils activation tests for the diagnosis of rocuronium hypersensitivity
13:27
Direct Oral Challenge to Remove a Low-risk Penicillin Allergy Label
13:39
Dual intracellular staining of CD154(CD40L) and cytokines at single cell level: a novel aid to document immediate hypersensitivity to amoxicillin
13:51
Hong Kong Drug Allergy De-labelling Initiative (HK-DADI): effectiveness, clinical outcomes and safety of a nurse-triaged penicillin allergy evaluation protocol
14:03
Polyethylene glycol and polysorbate 80 skin tests in the context of an allergic risk assessment for hypersensitivity reactions to anti-SARS-CoV-2 mRNA vaccines
14:15
Perioperative hypersensitivity reactions in a tertiary center in review: do we need provocation tests?
14:27
The diagnostic performance of basophil activation tests in penicillin allergy diagnosis using a meta-analysis
